Randomized Trial Evaluating Clinical Impact of RAPid IDentification and Susceptibility Testing for Gram-negative Bacteremia: RAPIDS-GN
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

Randomized Trial Evaluating Clinical Impact of RAPid IDentification and Susceptibility Testing for Gram-negative Bacteremia: RAPIDS-GN

Banerjee, Ritu;for the Antibacterial Resistance Leadership Group;Komarow, Lauren;for the Antibacterial Resistance Leadership Group;Virk, Abinash;for the Antibacterial Resistance Leadership Group;Rajapakse, Nipunie;for the Antibacterial Resistance Leadership Group;Schuetz, Audrey N;for the Antibacterial Resistance Leadership Group;Dylla, Brenda;for the Antibacterial Resistance Leadership Group;Earley, Michelle;for the Antibacterial Resistance Leadership Group;Lok, Judith;for the Antibacterial Resistance Leadership Group;Kohner, Peggy;for the Antibacterial Resistance Leadership Group;Ihde, Sherry;for the Antibacterial Resistance Leadership Group;Cole, Nicolynn;for the Antibacterial Resistance Leadership Group;Hines, Lisa;for the Antibacterial Resistance Leadership Group;Reed, Katelyn;for the Antibacterial Resistance Leadership Group;Garner, Omai B;for the Antibacterial Resistance Leadership Group;Chandrasekaran, Sukantha;for the Antibacterial Resistance Leadership Group;de St. Maurice, Annabelle;for the Antibacterial Resistance Leadership Group;Kanatani, Meganne;for the Antibacterial Resistance Leadership Group;Curello, Jennifer;for the Antibacterial Resistance Leadership Group;Arias, Rubi;for the Antibacterial Resistance Leadership Group;Swearingen, William;for the Antibacterial Resistance Leadership Group;Doernberg, Sarah B;for the Antibacterial Resistance Leadership Group;Patel, Robin;for the Antibacterial Resistance Leadership Group;
clinical infectious diseases 2021 Vol. 73 pp. e39-e46
121
ritu2021clinicalrandomized

Abstract

This randomized, controlled trial demonstrates that compared with conventional testing, a rapid phenotypic antibiotic susceptibility testing method implemented

Keywords

Access

URL:
https://academic.oup.com/cid/advance-article/58313...

Citation

ID: 266924
Ref Key: ritu2021clinicalrandomized
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
266924
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store